Eficacia de bevacizumab t贸pico en queratopat铆a lipoidea bilateral primaria
- 作者：M. Castro-Rebollo ; cinta.perezrico@gmail.com ; M.A. Montes-Molló ; n ; C. Pé ; rez-Rico ; M.A. Teus
- 关键词：Queratopatí ; a lipoidea bilateral primaria ; Bevacizumab tó ; pico ; Neovascularizació ; n corneal
- 刊名：Archivos de la Sociedad Espa帽ola de Oftalmolog铆a
- 出版年：2011
- 期刊代码：pca66_03656691
- 类别：med
- 出版时间：November 2011
- 卷：86
- 期：11
- 页码：374-376
- 文件大小：120 K
摘要
Case report
A 75-year-old man with bilateral idiopathic lipid keratopathy underwent a penetrating keratoplasty in the left eye. One month later, there was deep corneal neovascularisation extending across the bed and the graft-host interface, with a whitish opacity surrounding the vessels. Topical bevacizumab (25 mg/mL) was administered 4 times daily for 2 months with partial regression of corneal neovascularization.
Discussion
Topical bevacizumab may be useful in preventing a recurrence of lipid deposition after penetrating keratoplasty in patients with bilateral primary lipid keratopathy, although its long-term efficacy needs to be assessed.